Cipla Limited is an India-based global pharmaceutical company. The Company is engaged in manufacturing, developing and marketing a wide range of branded and generic formulations and Active ...

Cipla has launched a mobile application, CipAir, to aid in asthma screening in India, aiming to address the country's high asthma burden and underdiagnosis. India's pharmaceutical industry is poised ...

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Return on investment - most recent fiscal year 16.16 ...

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.

Cipla's shares are currently priced at Rs 1439.65, reflecting a modest rise of 0.82%. The 7-day simple moving average is Rs 1475.93. Cipla is currently valued at Rs 1437.65, with a daily increase of 0 ...

Bonus Oct 18, 1999 Nov 05, 1999 Oct 07, 1999 Bonus Ratio: 2 share(s) for every 1 shares held Rights Feb 03, 1995 Mar 02, 1995 May 03, 1995 Rights ratio: 4 share for every 50 held at a price of Rs ...

As a daily pill-taker, I’ve learned that the phrase “Out of sight, out of mind” holds all too true when it comes to staying on top of my medications. A pill case that looks and feels nice ...

By Claire Cain Miller Kate Conger and Mike Isaac Instagram and Facebook have recently blurred, blocked or removed posts from two abortion pill providers. Instagram also suspended the accounts of ...